8-K

OMB APPROVAL

OMB Number:  3235-0060

Expires:   January 31, 2008

Estimated average burden

hours per response:     38.0

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 19, 2006

AROTECH CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	0-23336	95-4302784
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

1229 Oak Valley Drive, Ann Arbor, Michigan	48108
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (800) 281-0356

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Potential persons who are to respond to the collection of

information contained in this form are not required to respond

unless the form displays a currently valid OMB control number.

Item 8.01Other Events.

On June 19, 2006, at the Annual Meeting of Stockholders of Arotech Corporation (the “Registrant”), the stockholders of the Registrant voted on the following proposals with the following results:

1.Fixing the number of Class I Directors at two:
	Votes For	Votes Withheld	Abstentions	Shares Not Voting
	87,801,315	8,345,370	0	0

2.Election of Class I Directors:
	Votes For	Votes Withheld	Abstentions	Shares Not Voting
Dr. Jay M. Eastman	87,801,315	8,345,370	0	0
Steven Esses	88,103,506	8,103,506	0	0
(Directors whose terms of office continued after the meeting were Robert S. Ehrlich, Jack E. Rosenfeld, Lawrence M. Miller, Edward J. Borey, and Seymour Jones)

3.Ratifying, for purposes of NASD Marketplace Rule 4350(i)(1)(C)(ii), the issuance in February, March and April of 2006 of warrants expiring March 31, 2008 to purchase up to 4,175,071 shares of the Company’s common stock at a price of $0.594 per share:
	Votes For	Votes Against	Abstentions	Shares Not Voting
	14,231,945	6,863,446	770,952	74,280,342

4.Amending the Company’s Amended and Restated Certificate of Incorporation in order to effect a one-for-fourteen reverse stock split:
	Votes For	Votes Against	Abstentions	Shares Not Voting
	85,362,793	10,520,295	263,596	0

On June 19, 2006, Arotech announced the above by press release, a copy of which is attached hereto as Exhibit 99.1.

Item 9.01Financial Statements and Exhibits.

As described above, the following Exhibits are furnished as part of this Current Report on Form 8-K:

Exhibit Number	Description
99.1	Press release dated June 19, 2006

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AROTECH CORPORATION
(Registrant)
By:	/s/ Robert S. Ehrlich
	Name:	Robert S. Ehrlich
	Title:	Chairman and CEO

Dated:June 19, 2006

EX-99.1

Exhibit 99.1

	Corporate News
Investor Relations Department Phone: 1-646-290-6400 www.arotech.com

FOR IMMEDIATE RELEASE

AROTECH REVERSE STOCK SPLIT AND WARRANT ISSUANCE PROPOSALS
RECEIVE OVERWHELMING APPROVAL FROM STOCKHOLDERS

One-for-fourteen reverse stock split to take effect at the opening of trading on June 21 -

Arotech ticker symbol will be ARTXD from June 21 to July 19

Ann Arbor, Michigan, June 19, 2006 - Arotech Corporation (NasdaqNM: ARTX) announced today that at its annual meeting of stockholders held this morning in New York, New York, Arotech’s stockholders overwhelmingly approved proposals to effect a one-for-fourteen reverse split of Arotech’s common stock, and to ratify, for purposes of NASD Marketplace Rule 4350(i)(1)(C)(ii), the issuance in February, March and April of 2006 of warrants expiring March 31, 2008 to purchase up to 4,175,071 shares of Arotech’s common stock at a price of $0.594 per share (approximately 298,220 shares after giving effect to the reverse split).

The resolution ratifying the reverse stock split received the support of over 88% of the total votes cast in person and by proxy on the proposal, being a majority of all outstanding shares of Arotech’s common stock entitled to vote on this proposal as required by Delaware law.

The resolution ratifying the warrant issuance received the support of over 65% of the total votes cast in person and by proxy on the proposal.

Stockholders also overwhelmingly re-elected directors Jay M. Eastman and Steven Esses.

The one-for-fourteen reverse stock split will take effect the morning of Wednesday, June 21, 2006. Pursuant to the rules of the Nasdaq Stock Market, Arotech’s stock ticker symbol will change from ARTX to ARTXD beginning on Wednesday, June 21 through and including Wednesday, July 19 (a period of twenty business days). The symbol will revert back to ARTX beginning with the opening of trading on Thursday, July 20, 2006.

“We appreciate this tremendous stockholder support for our growth and share capital management objectives,” said Robert S. Ehrlich, Chairman and CEO of Arotech. “We will work hard to justify our stockholders’ confidence.”

About Arotech Corporation

Arotech Corporation is a leading provider of quality defense and security products for the military, law enforcement and homeland security markets, including multimedia interactive simulators/trainers, lightweight armoring and advanced zinc-air and lithium batteries and chargers. Arotech operates through three major business divisions: Armor, Simulation and Training and Battery and Power Systems.

Arotech is incorporated in Delaware, with corporate offices in Ann Arbor, Michigan, and research, development and production subsidiaries in Alabama, Colorado, Michigan, California and Israel.

INVESTOR RELATIONS CONTACT:

Victor Allgeier, President

TTC Group, Inc.

+1-646-290-6400

vic@ttcominc.com

Except for the historical information herein, the matters discussed in this news release include forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, including Arotech’s ability to meet the conditions set forth in the decision of theNasdaq Listing Qualifications Panel. The words “believes,” “anticipates,” “expects,” “estimates” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements reflect management’s current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, readers are cautioned not to place undue reliance on these forward-looking statements, as they are subject to various risks and uncertainties that may cause actual results to vary materially. These risks and uncertainties include, but are not limited to, risks relating to: the ineffectiveness of Arotech’s internal control over financial reporting and disclosure controls and procedures; product and technology development; the uncertainty of the market for Arotech’s products; changing economic conditions; delay, cancellation or non-renewal, in whole or in part, of contracts or of purchase orders; Arotech’s ability to remain listed on the Nasdaq Stock Market in accordance with the Nasdaq’s $1.00 minimum bid price and other continued listing standards; dilution resulting from issuances of Arotech’s common stock upon conversion or payment of its outstanding convertible debt, which would be increasingly dilutive if and to the extent that the market price of Arotech’s stock decreases; and other risk factors detailed in Arotech’s most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2005, as amended, and other filings with the Securities and Exchange Commission. Arotech assumes no obligation to update the information in this release. Reference to Arotech’s website above does not constitute incorporation of any of the information thereon into this press release.

#####